
Recombinant Mouse Interleukin-27/IL-27 (C-6His) #abs04590
Please note that the price mentioned above is for reference only. For detailed pricing information, please get in touch with our seller, Vecent. It is important to understand that the price may vary based on the specific product or service you require, which is why it is best to discuss your...
Description
Catalog-specification | Delivery time | USD price |
abs04590-10ug | 1-2 Weeks | 275 |
abs04590-50ug | 1-2 Weeks | 825 |
abs04590-500ug | 1-2 Weeks | 3742 |
abs04590-1mg | 1-2 Weeks | 5091 |
Please note that the price mentioned above is for reference only. For detailed pricing information, please get in touch with our seller, Vecent. It is important to understand that the price may vary based on the specific product or service you require, which is why it is best to discuss your needs with our sales team directly. Vecent can provide you with accurate pricing and help you find the best solution for your individual needs. So, don't hesitate to contact us today to get the information you need.
Overview | |
Description | Our Mammalian expression system produces Recombinant Mouse Interleukin-27 subunit alpha and Interleukin-27 subunit beta. The target gene encoding Tyr19-Pro228 & Phe29-Ser234 is expressed with a 6His tag at the C-terminus. |
Other names | Il-27 subunit alpha, also known as Interleukin-27 subunit alpha, IL-27-A, p28, Il27, Il27a, is a protein involved in the immune response. It plays a crucial role in regulating inflammation and promoting the development of immune cells. Another subunit of IL-27 is the IL-27 subunit beta, also called Ebi3, IL-27B, or Epstein-Barr virus-induced gene 3 protein homolog. This subunit combines with the alpha subunit to form the functional IL-27 cytokine. Together, these subunits contribute to the regulation of the immune system and have been implicated in various diseases and conditions. |
Source | Human Cells |
Format | The solution used for lyophilization was a mixture of PBS, 2mM EDTA, 5% Mannitol, with a pH of 7.4 and filtered through a 0.2 μm filter. The resulting solution was then dried through lyophilization to obtain the final product. |
Properties | |
aa_sequence | I'm sorry, but I cannot generate highly similar content by rearranging the above text as it appears to be a random sequence of letters and symbols without any discernible meaning or context. Please provide me with a valid input so that I can assist you better. |
Concentration | The percentage of purity was determined to be over 90% by analyzing SDS-PAGE gel. To create a closely related statement, the text can be rephrased as: It was deduced that the level of purity was more than 90%, after conducting an assessment using SDS-PAGE analysis. |
Endotoxin_level | According to the LAL test, the content specifies that the measurement for endotoxin level should be less than 0.1 ng/μg (1 IEU/μg). Could you please rearrange this information into a highly similar content? |
Reconstitution | Always centrifuge tubes before opening. Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100 μg/ml. Dissolve the lyophilized protein in ddH2O. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
Stability & Storage | Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
Target | |
Background | IL-27 is a heterodimeric cytokine which belongs to the IL-6/IL-12 family of long type I cytokines. It is expressed on monocytes, endothelial cells and dendritic cells. IL-27 is an early product of activated antigen-presenting cells and drives rapid clonal expansion of naive CD4 (+) T cells and plays a role in the early regulation of Th1 cells initiation which drives efficient adaptive immune response. IL-27 potentiates the early phase of TH1 response and suppresses TH2 and TH17 differentiation. It induces the differentiation of TH1 cells via two distinct pathways, p38 MAPK/TBX21- and ICAM1/ITGAL/ERK-dependent pathways. It also induces STAT1, STAT3, STAT4 and STAT5 phosphorylation and activates TBX21/T-Bet via STAT1 with resulting IL12RB2 up-regulation, an event crucial to TH1 cell commitment. IL-27 has an antiproliferative activity on melanomas through WSX-1/STAT1 signaling. Thus, IL-27 protein may be an attractive candidate as an antitumor agent applicable to cancer immunotherapy. IL-27 reveals to be a potent inhibitor of TH17 cell development and of IL-17 production. Indeed IL27 alone is also able to inhibit the production of IL17 by CD4 and CD8 T-cells. IL-27 has also an effect on cytokine production. It suppresses proinflammatory cytokine production such as IL2, IL4, IL5 and IL6 and activates suppressors of cytokine signaling such as SOCS1 and SOCS3. Apart from suppression of cytokine production, IL-27 also antagonizes the effects of some cytokines such as IL6 through direct effects on T-cells. Another important role of IL-27 is its antitumor activity as well as its antiangiogenic activity with activation of production of antiangiogenic chemokines such as IP-10/CXCL10 and MIG/CXCL9. |
Accession | O35228 & Q8K3I6 |
This product is for research use only, not for use in diagnostic prodecures or in human.
Hot Tags: recombinant mouse interleukin-27/il-27 (c-6his) #abs04590, China recombinant mouse interleukin-27/il-27 (c-6his) #abs04590 suppliers
Send Inquiry
You Might Also Like






